Market Research Report
|Published by||Global Industry Analysts, Inc.||Product code||997863|
|Published||Content info||268 Pages
Delivery time: 1-2 business days
|Published: April 1, 2021||Content info: 268 Pages||
Global Tuberculosis Therapeutics Market to Reach $1.3 Billion by 2027
Amid the COVID-19 crisis, the global market for Tuberculosis Therapeutics estimated at US$979 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 3.6% over the period 2020-2027. Active TB, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$777.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Latent TB segment is readjusted to a revised 3.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $264.1 Million, While China is Forecast to Grow at 6.5% CAGR
The Tuberculosis Therapeutics market in the U.S. is estimated at US$264.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$265.6 Million by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.
Select Competitors (Total 37 Featured) -